Work

404 POSTER A phase I study of oral administration of the histone deacetylase (HDAC) inhibitor belinostat in patients (pts) with advanced solid tumors

Year: 2008

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(08)72338-3

Authors: W. Kelly, D. Petrylak, G. Blumenschein, U. Lassen, P. Buhl Jensen, J. DeBono

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2063112631

Cites:

Cited by: 1

Related to: 10